David Daly - 10 Jun 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Reporting relationship: Director
Issuer ticker: NEO
Reported as of: 10 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jun 2022, 20:41:42 UTC
Prior SEC filing: 08 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Ali Olivo, Attorney-in-Fact

Key filing fact

David Daly filed Form 4 for NEOGENOMICS INC (NEO) on 14 Jun 2022.

Key facts

This page summarizes David Daly's Form 4 filing for NEOGENOMICS INC (NEO).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 14 Jun 2022, 20:41.

Change

Previous filing in this sequence was filed on 08 Mar 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEO transaction

Common Stock

Award

Transaction value: $0
Shares: +15,556
Change %: +958%
Price: $0.000000
Shares after: 17,179
Date: 10 Jun 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +13,882
Change %
Price: $0.000000
Shares after: 13,882
Date: 10 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,882
Exercise price: $8.10

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,945
Date: 10 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,945
Exercise price: $43.39

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

Exhibit List: Exhibit 24 - Limited Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .